Madison, Wisconsin
United States
9
2021-06-03
9
2025-12-23
These are the the leading inventors for applications assigned to Cellectar Biosciences, Inc.:
Cellectar Biosciences, Inc. based in Madison, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Phospholipid-Flavagline Conjugates and Methods of Using the Same for Targeted Cancer Therapy
#2 | 2018-11-22 ✅ Patent 11,439,709 granted on 2022-09-13Phospholipid ether analogs as cancer-targeting drug vehicles
#3 | 2017-12-14 ✅ Patent 11,467,159 granted on 2022-10-11Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells
#4 | 2016-08-11 ✅ Patent 9,480,754 granted on 2016-11-01Phospholipid ether analogs as cancer-targeting drug vehicles
#5 | 2016-05-19 ✅ Patent 9,925,269 granted on 2018-03-27Phospholipid ether analogs as cancer-targeting drug vehicles
#6 | 2016-05-19 ✅ Patent 9,345,718 granted on 2016-05-24Phospholipid ether analogs as cancer-targeting drug vehicles
#7 | 2015-04-02 ✅ Patent 9,550,002 granted on 2017-01-24Phospholipid analogs as diapeutic agents and methods thereof
#8 | 2015-02-12 ✅ Patent 9,616,140 granted on 2017-04-11Fluorescent phospholipid ether compounds, compositions, and methods of use
#9 | 2015-01-29 ✅ Patent 9,579,406 granted on 2017-02-28Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
Also check out Cellectar Biosciences, Inc.'s (Madison, United States) applicant profile with 6 patent applications submitted.
311132 ⎘